Average Co-Inventor Count = 3.58
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Yeda Research and Develpment & Co. Ltd (60 from 1,168 patents)
2. Other (4 from 832,680 patents)
3. Alma Bio Therapeutics (3 from 3 patents)
4. Universitatsklinikum Hamburg-eppendorf (2 from 12 patents)
5. Stem Cell Medicine Ltd. (2 from 5 patents)
6. The Brigham and Women's Hospital, Inc. (1 from 1,370 patents)
7. Ben-gurion University of the Negev Research and Development Authority (1 from 343 patents)
8. Mor Research Applications Ltd. (1 from 101 patents)
9. The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center (1 from 48 patents)
10. The Weizmann Institute of Science (1 from 42 patents)
11. B.g. Negev Technologies and Applications Ltd. (1 from 34 patents)
12. De Staat Der Nederlanden, Vertegenwoordigd Door De Minister Van Welzijn, (1 from 4 patents)
13. Rijksuniversiteit Te Utrecht (1 from 1 patent)
14. Hadassa Medical Organization (1 from 1 patent)
15. Tel Hashomer Medical Research Infrastructure and Services Ltd. (126 patents)
71 patents:
1. 12038436 - Diagnosis of autoimmune disease
2. 11965885 - Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
3. 11852634 - Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
4. 11846636 - Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
5. 11480568 - Diagnosis of autoimmune diseases
6. 11047855 - Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
7. 11002735 - Identifying antigen clusters for monitoring a global state of an immune system
8. 10545144 - Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
9. 10288622 - Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
10. 10226517 - DNA vaccines encoding heat shock proteins
11. 10082503 - Identifying antigen clusters for monitoring a global state of an immune system
12. 9974843 - DNA vaccines encoding heat shock proteins
13. 9474744 - Beta-lactam compounds for treating diabetes
14. 9345691 - Beta-lactam compounds for enhancing T cell-mediated immune responses
15. 9345753 - Vaccine for alzheimer's disease